Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ASENAPINE MALEATE, with a corresponding US DMF Number 27086.
Remarkably, this DMF maintains an Active status since its submission on May 17, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 14, 2013, and payment made on May 13, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II